Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014–2018)

Author:

Gordon Stuart C12,Teshale Eyasu H3,Spradling Philip R3,Moorman Anne C3,Boscarino Joseph A4,Schmidt Mark A5,Daida Yihe G6,Rupp Loralee B7,Trudeau Sheri8,Zhang Jiaqi8,Lu Mei8,Teshale Eyasu H,Spradling Philip R,Moorman Anne C,Xing Jian,Zhong Yuna,Gordon Stuart C,Rupp Loralee B,Trudeau Sheri,Lu Mei,Li Jia,Akkerman Nonna,Zhou Yueren,Boscarino Joseph A,Daar Zahra S,Smith Robert E,Daida Yihe G,Trinacty Connie Mah,Lai Jonathan W,Nie Sixiang,Wong Carmen P,Schmidt Mark A,Donald Judy L,

Affiliation:

1. Department of Gastroenterology and Hepatology, Henry Ford Health System , Detroit Michigan , USA

2. Wayne State University School of Medicine , Detroit Michigan , USA

3. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia , USA

4. Department of Population Health Sciences, Geisinger Clinic , Danville, Pennsylvania , USA

5. Center for Health Research, Kaiser Permanente Northwest , Portland, Oregon , USA

6. Center for Integrated Health Care Research, Kaiser Permanente Hawaii , Honolulu, Hawaii

7. Center for Health Policy and Health Systems Research, Henry Ford Health System , Detroit Michigan , USA

8. Department of Public Health Sciences, Henry Ford Health System , Detroit Michigan , USA

Abstract

Abstract We compared rates of emergency department visits and hospitalizations between patients with hepatitis C virus who achieved sustained virological response after direct-acting antiviral therapy (case patients) and matched controls. Among 3049 pairs, case patients demonstrated lower rates of liver-related emergency department visits (P = .01) than controls; all-cause and liver-related hospitalization rates and number of hospitalized days were also lower in case patients (P < .001).

Funder

CHeCS

AbbVie

Genentech

Gilead Sciences

Janssen Pharmaceuticals,

Vertex Pharmaceuticals

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3